NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
01/24/2023
Back to search
Official data from USPTO
COMMAND-LINE ACCESS TO LIFE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
COMMAND-LINE ACCESS TO LIFE
ST13
US500000088373158Class
1, 5, 9, 29, 42
Filing
88373158
Registration
6557696
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
04/28/2023
Trademark type
Word
Nice classes
1, 5, 9, 29, 42
Filing date
04/05/2019
Registration date
11/16/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/16/2021
Last transaction
04/28/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
Drawing code
4
Owner type
99
Owner location
Cambridge, GB
Examiner
CALLOWAY,CHRISTINA DENISE
Law office
N40
Current location
TMO LAW OFFICE 122
Holders and representatives
Holders
Elpis Biomed Ltd
Representatives
Katrina G. Hull Markery Law LLC
Technical classification
Nice Classes
Class 1Class 5Class 9Class 29Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Stem cells for research purposes; Stem cells for scientific purposes; Stem cells other than for medical or veterinary purposes; Provision of skeletal myocytes for research purposes; Provision of cortical neurons for research purposes; Biological human tissue for research and scientific purposes; Biological tissue cultures other than for medical or veterinary purposes; Cultures of cell media; Chemical reagents for use in biotechnologyother than for medical or veterinary use; Nutritive agents for processing living cells; Semi-processed natural proteins for manufacturing food; Proteins for use in the manufacture of food products; Proteins for use in recombinant DNA technology
Class 5
Pharmaceuticals in the nature of cell therapeutics; Genetically and otherwise modified cells for medical or clinical use; Cells which are propagatedcultivated and expanded in bioreactors for medical or clinical use; Cells for the purpose of tissue regeneration for medical or clinical use; Living cells for medical use; Cells for medical use; Diagnostic preparations for medical and veterinary purposes; Cell preparations for drug screening; Cell preparations for genetic testingscreening; Stem cells for medical purposes; Stem cells for veterinary purposes; Cell growth media for growing cellstissue culture mediacytokinesantibodiesreagents for medicalmedical research and diagnostic or clinical use; Tissue culture mediagrowth factors in the nature of cell growthcell growth medianutritional supplements for in vitro culturingdevelopmentmaintenanceexpansionassay or manipulation of cells; Cell separation reagents for medical or clinical use; Dietary supplements; Protein supplements; nutrition supplements
Class 9
Downloadable computer software and computer hardware for the separation of biological and non-biological materials; Bioreactors for biomanufacturing; Bioreactors for research use; Bioreactor for cell culturing; Bioreactors for laboratory use; Downloadable and recorded computer-aided manufacturing software for the separation of biological and non-biological materials; Smart manufacturing system controls for laboratory robots and laboratory automation equipment featuring downloadable software incorporating algorithms to control laboratory robots and laboratory automation equipment; Electronic control units for laboratory robots and laboratory automation equipment featuring downloadable software incorporating algorithms to control laboratory robots and laboratory automation equipment; magnetic cell separation equipmentapparatus for the separation of cell populations for medical or clinical use
Class 29
Meat; Meat substitutes; Tissue engineered meat; Synthetic meat; Cultured meat; Laboratory-grown meat; Fishnot live
Class 42
Biotechnology research; Biotechnology testing; Stem cell research; Synthetic biology servicesbiological research; Stem cell biology servicesbiological research; Scientific services relating to the isolation and cultivation of human tissues and cells; Research and development in the field of microorganisms and cells; Research and development in relation to genetic testingscreening; Research and development in relation to drug screening; Cell separation technology services; Cell separation research services; Consultancy relating to biotechnology; Scientific and research consultancy relating to drug screening; Scientific and research consultancy relating to genetic screening; Scientific and research consultancy relating to cell therapy; Laboratory research in the field of drug discoverycell therapystem cellsmicroorganismshuman tissuessynthetic biology and biomanufacturing; Research on food; Research and development in the field of animal cells cultivated within bioreactors; Research in the reduction of carbon emissions; Providing temporary use of non-downloadablecloud-basedcomputer-aided manufacturing software for the separation of biological and non-biological materials
Publications
History of USPTO decisions and trademark events.
43 publications found
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
12/17/2022
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
12/14/2022
PRAM
POST REGISTRATION ACTION MAILED - SEC. 7
06/30/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/23/2022
ES7R
TEAS SECTION 7 REQUEST RECEIVED
02/01/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
11/16/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/31/2021
PUBO
PUBLISHED FOR OPPOSITION
08/31/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/11/2021
IUCN
NOTICE OF ALLOWANCE CANCELLED
07/28/2021
ATRQ
ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
03/09/2021
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
03/09/2021
APET
ASSIGNED TO PETITION STAFF
03/05/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/12/2021
EX1G
SOU EXTENSION 1 GRANTED
02/11/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/11/2021
EXT1
SOU EXTENSION 1 FILED
01/28/2021
EEXT
SOU TEAS EXTENSION RECEIVED
01/28/2021
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
12/21/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/28/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/02/2020
PUBO
PUBLISHED FOR OPPOSITION
06/02/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/13/2020
ALIE
ASSIGNED TO LIE
04/29/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/23/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/10/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/10/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/10/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/08/2020
GNRT
NON-FINAL ACTION E-MAILED
01/08/2020
CNRT
NON-FINAL ACTION WRITTEN
01/08/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/19/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/19/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/19/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/24/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/24/2019
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
06/26/2019
GPRA
PRIORITY ACTION E-MAILED
06/26/2019
CPRA
PRIORITY ACTION WRITTEN
06/26/2019
DOCK
ASSIGNED TO EXAMINER
06/17/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/23/2019
NWAP
NEW APPLICATION ENTERED
04/09/2019
Continuous trademark protection
Get notified about every new filing that threatens COMMAND-LINE ACCESS TO LIFE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.